Flow Index: a New Method for Assessing Respiratory Drive in Critically Ill Patients Based on Electrical Impedance Tomography
Launched by RUIJIN HOSPITAL · Mar 10, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Research Title: Flow Index: A Novel Method Based on Electrical Impedance Tomography for Assessing Respiratory Drive in Critically Ill Patients - A Prospective Single-Center Study
Research Summary 1.1 Abstract
Research Title: Flow Index: A Novel Method Based on Electrical Impedance Tomography for Assessing Respiratory Drive in Critically Ill Patients - A Prospective Single-Center Study
Study Overview: This study aims to validate the reliability and clinical application value of a new parameter - Flow Index derived from Electrical Impedance Tomography (EIT) in assessing respiratory drive i...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years,
- • Acute respiratory failure requiring respiratory support
- • Expected duration of support \>24 hours.
- Exclusion Criteria:
- • Contraindications to EIT (e.g., implantable cardiac devices)
- • Severe haemodynamic instability (norepinephrine \>0.5 μg/kg/min)
- • Chest gallery deformity
- • Recent thoracic surgery
- • Pregnancy
- • Expected survival \<24 hours.
About Ruijin Hospital
Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution in China recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, Ruijin Hospital integrates cutting-edge medical practices with rigorous scientific investigation. The hospital's multidisciplinary teams are dedicated to developing new therapeutic approaches, improving patient outcomes, and contributing to global medical knowledge. As a sponsor of clinical trials, Ruijin Hospital ensures adherence to the highest ethical standards and regulatory compliance, fostering an environment of collaboration and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Shanghai, , China
Patients applied
Trial Officials
Hongping Qu
Study Chair
Department of Critical Care Medicine，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine
Jialin Liu
Study Director
Department of Critical Care Medicine，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine
rui zhang
Principal Investigator
Department of Critical Care Medicine，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported